Search Results 441-450 of 15985 for clindamycin

  1. A Study to Develop a Biobank of Samples from Patients Undergoing Therapy with PCSK9 Inhibitors - Mayo Clinic

    Develop a biobank of samples from patients undergoing therapy with PCSK9 inhibitors (FDA- approved in 2015, therapeutics for hypercholesterolemia) with the goal ...

  2. An Extension Study of Trastuzumab Emtansine in Patients Treated with the Same Drug Regimen in a Previous Study - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF Bronchiectasis - Mayo Clinic

    The DRCFI treatment will influence the time to first pulmonary exacerbation compared to placebo. Participation eligibility. Participant eligibility includes age ...

  4. Ixekizumab (subcutaneous route) - Mayo Clinic

    Ixekizumab injection is used to treat moderate-to-severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) ...

  5. Information for Residents of Chicago

    Request an appointment at Mayo Clinic in Arizona, Florida and Minnesota. You usually don't need a doctor's referral to schedule an appointment.

  6. Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer - Mayo Clinic

    Erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...

  7. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...

  8. Bimekizumab-bkzx (subcutaneous route) - Mayo Clinic

    Bimekizumab-bkzx injection is used to treat moderate to severe plaque psoriasis, which is a skin disease with red patches and white scales that do not go away.

  9. Focus areas - Liquid Biopsy and Translational Immunogenomics: Aadel A. Chaudhuri - Mayo Clinic Research

    Minimal residual disease (MRD) detection using circulating tumor DNA (ctDNA). MRD detection from proximal biofluids to anticipate cancer relapse.

  10. Pain Medicine - Conditions treated - Mayo Clinic

    Mayo Clinic pain medicine specialists treat a wide range of conditions, including the following. Not all services are available at each location.